chronic kidney disease
-
AstraZeneca’s Dapagliflozin receives CDSCO approval
The drug is used to treat patients with Chronic Kidney Disease and heart failure AstraZeneca India has received the Central…
Read More » -
Strides Shasun receives USFDA approval for Cinacalcet Hydrochloride Tablets
Strides Shasun Limited today announced that its wholly owned subsidiary Strides Pharma Global Pte. Limited has received final approval for…
Read More »